Cathepsin B, Airway Pathogens, and Inflammation in the Lower Airways of Children With Cystic Fibrosis
Cathepsin B, Atemwegspathogene und Entzündung in den unteren Atemwegen von Kindern mit zystischer Fibrose
Pediatric Pulmonology · 2026-08 · 61 (8)
DOI: 10.1002/ppul.71793 ↗Auf einen Blick
In 52 Kindern mit CF und 161 ohne CF wurden pro- und reife Cathepsin-B-Formen in der BALF untersucht. Beide waren mit Pathogenen und Entzündungsmarkern assoziiert.
Fragestellung
Wie hängen pro-CTSB und reife CTSB-Aktivität mit CF-typischen Pathogenen und Atemwegsentzündung bei Kindern mit und ohne CF zusammen?
Methode
Querschnittstudie mit BALF aus klinisch indizierten Bronchoskopien; CTSB per ELISA, Aktivitätsassay und Western Blot; Keime per qPCR und Sequenzierung.
Ergebnisse
Pro-CTSB und CTSB-Aktivität waren in CF-BALF und bei positiver Staphylococcus-aureus-Kultur erhöht. Beide korrelierten mit Entzündungsmarkern; pro-CTSB mit FEV1/FVC negativ.
Schlussfolgerung der Autor:innen
BALF-CTSB könnte ein CF-spezifischer Biomarker für infektionsbedingte Entzündung und obstruktive Lungenerkrankung sein, die durch Pathogeninteraktionen geprägt ist.
Kernaussagen
- Pro-CTSB und CTSB-Aktivität waren in CF erhöht
- Assoziationen mit Staphylococcus aureus, Aspergillus spp. und Entzündungsmarkern
- Pro-CTSB korrelierte negativ mit FEV1/FVC in CF
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, online erschienen am 14.08.2026. Verfasst von Matthew K Fought und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Sleep Medicine, University of Washington and Seattle Children's Hospital, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cathepsin B, Bronchoalveolar Lavage Fluid. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, Cystic Fibrosis Foundation, NIH HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Dysregulated protease activity contributes to airway inflammation and tissue remodeling in cystic fibrosis (CF); however, the role of the lysosomal cysteine protease Cathepsin B (CTSB) remains incompletely defined. This cross‐sectional study investigates relationships between pro‐CTSB and mature CTSB activity with CF‐specific pathogens and airway inflammation in children with and without CF.
Methods
Bronchoalveolar lavage fluid (BALF) was collected from clinically indicated bronchoscopies in children ( N = 52 CF, N = 161 non‐CF). CTSB was interrogated using ELISA, fluorogenic activity assay, and Western blot analysis to distinguish pro‐ and mature CTSB. Total bacterial and total fungal load (TFL) were quantified by quantitative polymerase chain reaction, and community composition was determined by 16S bacterial and 18S fungal sequencing. Concentrations of proinflammatory cytokines and neutrophil elastase (NE) were measured via Luminex multiplatform and a spectrophotometric assay, respectively. Analyses included Spearman's rank correlations and Wilcoxon rank‐based tests.
Results
Pro‐CTSB and CTSB activity were significantly ( p < 0.01) elevated in CF BALF and in samples with a positive Staphylococcus aureus airway culture. Pro‐CTSB concentrations correlated with staphylococcal relative abundance (RA, = 0.25, p < 0.02) and reduced bacterial diversity ( = −0.41, p < 0.01). Mature CTSB activity correlated with TFL ( = 0.50, p < 0.05) and Aspergillus spp. RA ( = 0.36, p < 0.04). Western blot analysis confirmed pro‐CTSB expression and mature CTSB in BALF with measurable activity. Both CTSB measures correlated strongly with NE and proinflammatory cytokines ( ≥ 0.47, p < 0.001). Pro‐CTSB concentrations negatively correlated with FEV1/FVC measurements in CF ( = −0.32, p = 0.05).
Conclusions
BALF CTSB concentration may serve as a CF‐specific biomarker of infection‐related inflammation and obstructive lung disease driven by specific pathogen interactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary and Sleep Medicine, University of Washington and Seattle Children's Hospital, Seattle, Washington, USA.
- Department of Microbiology & Immunology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- Colorado School of Public Health, University of Colorado Denver, Aurora, Colorado, USA.
- University of Colorado School of Medicine, Aurora, Colorado, USA.
ORCID-Profile: Matthew K Fought, Brandie D Wagner
Förderung
- NHLBI NIH HHS
- Cystic Fibrosis Foundation
- NIH HHS
- National Institutes of Health
Zitieren
APA
Fought, M. K., O'Connor, J. B., Wagner, B. D., Quinn, A. C., Kirk Harris, J., & Laguna, T. A. (2026). Cathepsin B, Airway Pathogens, and Inflammation in the Lower Airways of Children With Cystic Fibrosis. Pediatric Pulmonology, 61(8). https://doi.org/10.1002/ppul.71793
Vancouver
Fought MK, O'Connor JB, Wagner BD, Quinn AC, Kirk Harris J, Laguna TA. Cathepsin B, Airway Pathogens, and Inflammation in the Lower Airways of Children With Cystic Fibrosis. Pediatric Pulmonology. 2026;61(8). doi:10.1002/ppul.71793
BibTeX
@article{Fought2026,
author = {Fought, Matthew K and O'Connor, John B and Wagner, Brandie D and Quinn, Alexandra C and Kirk Harris, J and Laguna, Theresa A},
title = {Cathepsin B, Airway Pathogens, and Inflammation in the Lower Airways of Children With Cystic Fibrosis},
journal = {Pediatric Pulmonology},
year = {2026},
volume = {61},
number = {8},
doi = {10.1002/ppul.71793}
}
EUVIMED